当前位置:首页 - 行情中心 - 圣达生物(603079) - 财务分析 - 现金流量表

圣达生物

(603079)

  

流通市值:23.31亿  总市值:23.31亿
流通股本:1.89亿   总股本:1.89亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金409,315,372.21220,208,923.66846,046,400.65639,336,489.2
  收到的税费返还11,340,301.836,264,366.9440,609,928.7220,142,986.25
  收到其他与经营活动有关的现金19,772,006.5710,762,471.5716,791,902.4618,473,388.23
  经营活动现金流入小计440,427,680.61237,235,762.17903,448,231.83677,952,863.68
  购买商品、接受劳务支付的现金299,782,615.88164,585,692.05532,280,904.15437,142,455.42
  支付给职工以及为职工支付的现金81,734,936.7849,627,540.74140,113,315.43107,553,375.64
  支付的各项税费30,687,311.3916,791,816.2350,074,800.6834,154,476.84
  支付其他与经营活动有关的现金17,494,288.659,454,338.3142,094,659.6931,437,678.07
  经营活动现金流出小计429,699,152.7240,459,387.33764,563,679.95610,287,985.97
  经营活动产生的现金流量净额10,728,527.91-3,223,625.16138,884,551.8867,664,877.71
二、投资活动产生的现金流量:
  收回投资收到的现金783,723,600450,812,3001,372,286,3751,042,286,375
  取得投资收益收到的现金2,205,264.54947,387.442,064,913.511,325,624.94
  处置固定资产、无形资产和其他长期资产收回的现金净额260,037.2920,6701,133,886.97224,025.99
  投资活动现金流入小计786,188,901.83451,780,357.441,375,485,175.481,043,836,025.93
  购建固定资产、无形资产和其他长期资产支付的现金51,154,666.7336,214,237.31145,682,849.07107,304,649.59
  投资支付的现金620,000,000290,000,0001,547,008,315.291,047,008,315.29
  投资活动现金流出小计671,154,666.73326,214,237.311,692,691,164.361,154,312,964.88
  投资活动产生的现金流量净额115,034,235.1125,566,120.13-317,205,988.88-110,476,938.95
三、筹资活动产生的现金流量:
  吸收投资收到的现金--266,879,190264,529,990
  取得借款收到的现金17,000,00013,000,000141,500,000123,500,000
  筹资活动现金流入小计17,000,00013,000,000408,379,190388,029,990
  偿还债务支付的现金2,710,0002,000,00079,000,00079,000,000
  分配股利、利润或偿付利息支付的现金14,061,744.32,035,638.647,813,279.85,647,274.67
  支付其他与筹资活动有关的现金609,542.08471,842.082,496,052.922,089,389.41
  筹资活动现金流出小计17,381,286.384,507,480.7289,309,332.7286,736,664.08
  筹资活动产生的现金流量净额-381,286.388,492,519.28319,069,857.28301,293,325.92
四、汇率变动对现金及现金等价物的影响-6,211,144.51-3,083,736.08-1,487,249.359,278
五、现金及现金等价物净增加额119,170,332.12127,751,278.17139,261,170.93258,490,542.68
  加:期初现金及现金等价物余额402,769,768.25402,769,768.25263,508,597.32263,508,597.32
  期末现金及现金等价物余额521,940,100.37530,521,046.42402,769,768.25521,999,140
补充资料:
  净利润24,521,575.34-69,264,339.67-
  资产减值准备887,329.32-10,153,834.42-
  固定资产和投资性房地产折旧38,565,337.85-68,918,855.7-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧38,565,337.85-68,918,855.7-
  无形资产摊销3,709,063.09-7,533,701.17-
  长期待摊费用摊销965,484.46-4,924,416.25-
  处置固定资产、无形资产和其他长期资产的损失563,488.57-477,311.75-
  固定资产报废损失--381,244.7-
  公允价值变动损失-54,817.38--49,263.4-
  财务费用6,355,785.38-2,425,956.35-
  投资损失-2,157,615.22--2,064,913.51-
  递延所得税-128,674.05--6,222,855.73-
  其中:递延所得税资产减少513,182.11--6,941,924.36-
    递延所得税负债增加-641,856.16-719,068.63-
  存货的减少-38,775,400.89--2,887,112.73-
  经营性应收项目的减少-14,508,024.89--24,848,938.01-
  经营性应付项目的增加-11,173,476.93-9,150,535.65-
  其他1,445,338.41-138,180-
  现金的期末余额521,940,100.37-402,769,768.25-
  减:现金的期初余额402,769,768.25-263,508,597.32-
  现金及现金等价物的净增加额119,170,332.12-139,261,170.93-
公告日期2026-08-282026-04-272026-04-272025-10-30
审计意见(境内)标准无保留意见
TOP↑